You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In PLOS this week: method that combines genetic and lab test results from EHRs, leptospirosis microtranscriptome profiles, and more.
The assay underwent clinical validation at three centers in Singapore and 5,248 patients were ultimately screened using the test.
The firm's platform, dubbed HNKlear, uses methylation-specific PCR to detect microRNA biomarkers in a patient's blood sample following frontline cancer treatment.
The company and its collaborators previously published a study linking saliva concentrations of multiple microRNAs with concussion duration and symptoms in children.
In PLOS this week: functional effect of adiponectin-linked variants, sequencing reveals regional differences among Swedes, and more.
Three research teams profiled proteomic, genomic, and other features in lung adenocarcinomas in Asia and other parts of the world, including cases in never-smokers.
In PNAS this week: effect of premature termination codons in the DMD gene, knock-down of DUX4 in facioscapulohumeral muscular dystrophy, and more.
In Nucleic Acids Research this week: tool to track co-expression networks, tool to prioritize variants in rare diseases, and more.
A Broad Institute-led team found that differences by ancestry could affect not only how cancer develops but also treatment approaches.
In Science this week: a microRNA regulates extracellular vesicle secretion from prostate cancer cells, and more.
The Wall Street Journal reports on gaps in COVID-19 testing affecting less affluent urban areas and rural locations.
According to NBC News, new SARS-CoV-2 variants are making it harder for researchers to model the course of the pandemic.
The New York Times reports that experts say President Joe Biden's goal of vaccinating 1 million people a day in the US in the next 100 days is too low a bar.
In Science this week: single-cell lineage tracing technique applied to study lung cancer metastasis, and more.